HK1092840A1 - Use of a polypeptides - Google Patents

Use of a polypeptides

Info

Publication number
HK1092840A1
HK1092840A1 HK06113389.6A HK06113389A HK1092840A1 HK 1092840 A1 HK1092840 A1 HK 1092840A1 HK 06113389 A HK06113389 A HK 06113389A HK 1092840 A1 HK1092840 A1 HK 1092840A1
Authority
HK
Hong Kong
Prior art keywords
polypeptides
Prior art date
Application number
HK06113389.6A
Other languages
English (en)
Inventor
Norbert Tennagels
Aimon Kannt
Harald Thuering
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1092840A1 publication Critical patent/HK1092840A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK06113389.6A 2003-05-22 2006-12-06 Use of a polypeptides HK1092840A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323081A DE10323081A1 (de) 2003-05-22 2003-05-22 Verwendung eines Polypeptides
PCT/EP2004/004428 WO2004104220A2 (fr) 2003-05-22 2004-04-27 Utilisation d'un polypeptide

Publications (1)

Publication Number Publication Date
HK1092840A1 true HK1092840A1 (en) 2007-02-16

Family

ID=33441119

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113389.6A HK1092840A1 (en) 2003-05-22 2006-12-06 Use of a polypeptides

Country Status (15)

Country Link
US (1) US7732151B2 (fr)
EP (1) EP1627073A2 (fr)
JP (1) JP4740858B2 (fr)
KR (1) KR20060015290A (fr)
CN (1) CN100560732C (fr)
AU (1) AU2004241327B2 (fr)
BR (1) BRPI0410783A (fr)
CA (1) CA2526697A1 (fr)
DE (1) DE10323081A1 (fr)
HK (1) HK1092840A1 (fr)
IL (1) IL172008A (fr)
MX (1) MXPA05012521A (fr)
NO (1) NO20055990L (fr)
RU (1) RU2395813C2 (fr)
WO (1) WO2004104220A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170165230A1 (en) 2014-04-09 2017-06-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
CN113933463B (zh) * 2021-10-14 2024-04-02 丽江英煌集生物工程有限公司 一种玛咖多肽活性的快速分检装置及分检方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2166871A1 (fr) * 1993-07-29 1995-02-09 Neill A. Giese Essais pour la fonction recepteur
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
AU5965896A (en) * 1995-06-07 1996-12-30 Sugen, Inc. Screening assays for compounds
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
JP2002512685A (ja) * 1997-01-15 2002-04-23 テリック・インコーポレイテッド インスリン受容体活性のモジュレーター
WO2000075167A2 (fr) * 1999-06-09 2000-12-14 Ljl Biosystems, Inc. Bioanalyses realisees au cours de la phosphorylation
US6203994B1 (en) * 1997-12-05 2001-03-20 Pharmacia & Upjohn Company Fluorescence-based high throughput sereening assays for protein kinases and phosphatases

Also Published As

Publication number Publication date
NO20055990L (no) 2006-02-14
JP4740858B2 (ja) 2011-08-03
KR20060015290A (ko) 2006-02-16
BRPI0410783A (pt) 2006-06-20
CN100560732C (zh) 2009-11-18
US7732151B2 (en) 2010-06-08
AU2004241327A1 (en) 2004-12-02
RU2005140091A (ru) 2006-05-10
CN1795273A (zh) 2006-06-28
EP1627073A2 (fr) 2006-02-22
DE10323081A1 (de) 2004-12-16
JP2007512802A (ja) 2007-05-24
IL172008A (en) 2011-12-29
WO2004104220A2 (fr) 2004-12-02
CA2526697A1 (fr) 2004-12-02
MXPA05012521A (es) 2006-05-25
US20080020399A1 (en) 2008-01-24
WO2004104220A3 (fr) 2005-06-09
RU2395813C2 (ru) 2010-07-27
AU2004241327B2 (en) 2010-03-25

Similar Documents

Publication Publication Date Title
PL372902A1 (en) New use
GB0206048D0 (en) Use
GB0227666D0 (en) Use
AU2003235493A8 (en) Multifunctional polypeptides
SG113501A1 (en) Determination of a movable gantry position
GB0217056D0 (en) Use
GB0213878D0 (en) Use
EP1596813A4 (fr) Polypeptides exprimes par les poumons
HK1092840A1 (en) Use of a polypeptides
GB0206838D0 (en) Use
GB0313913D0 (en) New use
GB0230343D0 (en) Use
GB0204720D0 (en) Novel use
GB0309120D0 (en) A set of parts
GB0210682D0 (en) Novel use
GB0329173D0 (en) Polypeptides
GB0310935D0 (en) Polypeptides
GB0302177D0 (en) Polypeptides
GB0201876D0 (en) Polypeptides
GB0229442D0 (en) Use
GB0327619D0 (en) New use
GB0329089D0 (en) A crutch
GB0302608D0 (en) A portable de-fibrillator
GB0200531D0 (en) New use
GB0203207D0 (en) New use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140427